Thymalin

Thymalin is a thymic peptide preparation studied for immune system restoration and modulation, particularly in aging-related immune decline (immunosenescence) and post-illness immune reconstitution. It has been investigated in longitudinal anti-aging studies in Eastern European research literature with reported improvements in immune biomarkers.

Moderate evidence Unregulated Immune

Written by WhatPeptide Editorial Team · Last updated 2026-03-17

Half-life

Short; varies by component peptides

Dosage range

5-20 mg intramuscularly per course (10-30 day cycles; literature context)

Administration

Subcutaneous injection

Research level

Moderate

How Thymalin works

Thymalin contains a mixture of low-molecular-weight thymic peptides that stimulate T-lymphocyte differentiation and maturation, enhancing cellular immune responses and restoring age-related decline in thymic output. Proposed mechanisms include promotion of Th1 cytokine profiles, increased NK cell activity, and restoration of CD4+/CD8+ T-cell ratios toward more youthful patterns. Long-term studies in elderly populations reported reductions in infection frequency and all-cause mortality, though these findings come primarily from observational Russian clinical research.

Also known as: Thymus peptide complex, Tactivin-related, Thymus extract peptide

Research relevance

Immune Support

Moderate relevance 70

Side effects & safety

Injection site reactions Rare hypersensitivity Transient immune activation symptoms

Contraindications

Active autoimmune disease without supervision

Organ transplant recipients on immunosuppression

Pregnancy

Consult a healthcare provider before use if any of these apply to you.

Key studies

FAQ

What is Thymalin? +

What is Thymalin researched for? +

Thymalin has the strongest research relevance for Immune Support. Evidence is supported by moderate clinical and preclinical evidence.

What are the side effects of Thymalin? +

Reported side effects include Injection site reactions, Rare hypersensitivity, Transient immune activation symptoms. Key contraindications: Active autoimmune disease without supervision; Organ transplant recipients on immunosuppression; Pregnancy.

Is Thymalin FDA approved? +

Thymalin is not FDA-approved. It is available as a research compound or through compounding pharmacies in some jurisdictions.

How is Thymalin administered? +

Thymalin is typically administered via subcutaneous route. Researched dosage range: 5-20 mg intramuscularly per course (10-30 day cycles; literature context). Half-life: Short; varies by component peptides.

Explore similar peptides

Thymosin Alpha-1

Moderate evidence

Immune

An immunomodulatory peptide approved in over 35 countries (as Zadaxin) for hepatitis B/C and as an immune adjunct. Not FDA-approved in the US. Was placed on FDA Category 2 list (September 2023 – September 2024) before being removed when the nominator withdrew. Current regulatory status is in flux; FDA continues to flag safety concerns.

Vilon

Preliminary evidence

Immune

Vilon is a synthetic dipeptide (Lys-Glu) derived from the thymus gland, studied as an immune-regulatory bioregulator that promotes thymic function restoration and has been investigated in the same anti-aging peptide bioregulator research tradition as Epithalon and Thymalin. It represents one of the shortest bioactive peptides studied for immune modulation.

VIP

Preliminary evidence

Immune

Vasoactive Intestinal Peptide (VIP) is an endogenous 28-amino acid neuropeptide with potent anti-inflammatory, vasodilatory, and immunomodulatory properties, studied most notably in the context of Chronic Inflammatory Response Syndrome (CIRS) and pulmonary arterial hypertension. Intranasal delivery targets pulmonary and systemic anti-inflammatory pathways.